• DR. P. KOKILA
• Dr. S. R. PHOLTAN RAJEEV
• PROF. DR. M. THIRUTHANI

Abstract:Human got diseases from Bacterial and Fungal infection commonly therefore siddha drugs should undergo with block the spread of microbial contamination of the body. Prepared medicine can enhance and lost their antimicrobial activity by the procedure of compound drugs this was a general rule of all system of medicine because of phytochemical reaction between the raw materials on process reactions. In this study was concluded as; Siddha Drug – Pattai Chooranam was Resistant for 10µl, 20 µl, 30µl Sample Loads to Escherichia coli, Staphylococcus aureus, Klebsiella sps., Candida sp. With control of antimicrobial activities against both bacterial and fungal pathogens (0.5 MCF) using agar well diffusion method along with a standard broad-spectrum antibiotics Chloramphenicol (30mcg) for bacterial pathogens and Ketoconazole (30mcg) for fungal pathogen. This Pattai Chooranam may be works to promote immune enhancer to body against microbial activity inside the body therefore it resist selected pathogens.

Siddha Compound Medicine, Pattai Chooranam, Human Pathogen, antimicrobial activity.

"Antimicrobial activity of siddha drug pattai chooranam", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.726-730, June-2019, Available :http://www.jetir.org/papers/JETIR1906688.pdf

"Antimicrobial activity of siddha drug pattai chooranam", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp726-730, June-2019, Available at : http://www.jetir.org/papers/JETIR1906688.pdf